DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Biopol Chemicals Limited — Board Meeting Intimation

NSE 1 hr ago·16 Oct 2026, 11:54 am

Biopol Chemicals

Biopol Chemicals Limited has announced that its Board of Directors will meet on November 5, 2026, to review the company's unaudited financial results for the first half of the fiscal year ending September 2026. This interim reporting is a standard corporate procedure designed to keep shareholders informed about the company's financial health between the annual results.

For investors, this update is a key milestone as it provides the first glimpse into the company's operational performance for the current financial cycle. It helps the market assess whether the business is on track to meet its targets and can influence the stock's valuation based on the reported earnings and operational outlook.

Investors should watch for the company's commentary on its key performance indicators, such as revenue growth and margins. The market will likely react to any guidance provided during the earnings discussion, so keeping an eye on the official release of these results is essential for making informed investment decisions.